Clinical Trials
18 trialsNCT04918186 2026-05-12
IPROC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT04651127 2026-03-10
Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer
Sun Yat-sen University
Phase 1/2 Terminated
NCT07392060 2026-02-06
A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment
Shanghai Jiatan Pharmatech Co., Ltd
Phase 3 Not yet recruiting
NCT07363330 2026-01-26
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
Zhongnan Hospital
Phase 2 Not yet recruiting
NCT06416696 2026-01-02
Toripalimab for High-risk Locally Advanced Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT05427396 2025-12-03
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT07092696 2025-07-30
Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06093438 2025-03-11
Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1/2 Recruiting
NCT06028672 2025-02-06
TA56
Peking Union Medical College Hospital
Phase NA Recruiting
NCT06020755 2024-12-31
TA7
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06548763 2024-08-12
Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
Fudan University
Phase 2 Not yet recruiting
NCT05955105 2024-05-21
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Innolake Biopharm
Phase 1/2 Recruiting
NCT06256224 2024-04-24
Toripalimab Combined With Definitive CCRT for LACC Patients
Ruijin Hospital
Phase NA Recruiting
NCT05342506 2022-04-22
Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04731038 2021-09-17
Combination Therapy for First Line Treatment of Advanced Cervical Cancer
Ruijin Hospital
Phase 1 Unknown
NCT04973904 2021-07-22
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04395612 2021-05-21
CQGOG0101
Chongqing University Cancer Hospital
Phase 2 Unknown
NCT04368273 2020-04-29
CCRT+PD-1
Peking University Third Hospital
Phase 1/2 Unknown